Bicycle Therapeutics Plc (BCYC)
7.48
+0.05
(+0.67%)
USD |
NASDAQ |
Dec 12, 16:00
7.48
0.00 (0.00%)
After-Hours: 18:37
Bicycle Therapeutics Free Cash Flow: -242.07M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Adaptimmune Therapeutics Plc | -193.83M |
| Biodexa Pharmaceuticals Plc | -14.30M |
| NuCana Plc | -18.19M |
| Autolus Therapeutics Plc | -306.93M |
| Mereo BioPharma Group Plc | -33.02M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -70.63M |
| Cash from Investing (Quarterly) | -0.6709M |
| Cash from Financing (Quarterly) | -0.0297M |
| Free Cash Flow Per Share (Quarterly) | -1.029 |
| Free Cash Flow to Equity (Quarterly) | -69.80M |
| Free Cash Flow to Firm (Quarterly) | -71.27M |
| Free Cash Flow Yield | -46.77% |